2015 年 2 月 17 日发表在《美国医学协会杂志》上的一项研究表明，与低分子量肝素 (LMWH) 相比，在日常临床实践中使用磺达肝素治疗 NSTEMI 患者能够降低严重出血和死亡风险，这一发现支持了以往的试验结果。但是，两种治疗手段的复发性心梗率和卒中率相似。

Complete rather than culprit-only revascularization appears to pay off long-term for patients with multivessel disease presenting with non-ST-segment elevation MI (NSTEMI), suggests an observational ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

LONDON -- Routine coronary intervention was safe and somewhat beneficial for older people with non-ST-segment elevation myocardial infarction (NSTEMI) in the SENIOR-RITA trial, unique for being ...

Sophia Antipolis, 19 Nov. 2015: Thrombus aspiration before percutaneous coronary intervention (PCI) does not improve 12-month clinical outcomes in patients with non-ST-elevation myocardial infarction ...

The conventional classification of acute myocardial infarction (AMI) into ST-segment elevation (STEMI) and non-ST-segment elevation (NSTEMI) has long guided clinical decision-making. However, emerging ...

Results of the ISAR-REACT 4 study have shown that combined therapy of abciximab and unfractionated heparin is not associated with a lower 30-day rate of death, large recurrent myocardial infarction, ...

The American College of Cardiology and the American Heart Association have jointly released revised Guidelines for the Management of Patients with Unstable Angina (UA)/Non-ST- Elevation Myocardial ...

Medical Management/Treatment Initial treatment for suspected STEMI and NSTEMI requires a loading dose of nonenteric coated ASA at 162 to 325 mg (unless contraindicated), nitroglycerin in response to ...

An invasive strategy vs. optimal medical therapy alone after a non-ST-elevation myocardial infarction (NSTEMI) in older adults did not affect the combined risk of cardiovascular death or MI, although ...